Brain magnetic resonance imaging software to support dementia diagnosis in routine clinical practice: a barrier to adoption study in the National Health Service (NHS) England
Griffanti, L.; Serres, F.; Cini, L.; Walsh, J.; Hanayik, T.; Pervaiz, U.; Smith, S.; Johansen-Berg, H.; Rose, J.; Bajre, M.
Show abstract
With the rise in numbers of people living with dementia and new disease modifying therapies entering the market, there is increasing need for brain magnetic resonance imaging (MRI) for diagnosis and safety monitoring. The number of scans that need reporting is expected to rapidly grow. Clinical radiology reports are currently largely qualitative and variable in structure and content. By contrast, research software typically uses automated methods to extract quantitative metrics from brain scans. To better understand the unmet clinical need for brain reporting software for dementia we conducted a barrier to adoption study using the Lean Assessment Process (LAP)methodology. We first assessed the role of brain imaging in the diagnostic pathway for people with suspected dementia in the NHS in England. We then explored the views of (neuro)radiologists, neurologists and psychiatrists on the potential benefits and level of acceptance of software to support brain MRI analysis, using the FMRIB software library (FSL) as a technology exemplar. The main perceived utilities of the proposed software were: increased diagnostic confidence; support for delivery of disease modifying therapies; and the possibility to compare individual results with population norms. In addition to assessment of global atrophy, hippocampal atrophy and white matter hyperintensities, additional user requirements included assessment of microbleeds, segmentation of multiple brain structures, clear information about the control population used for reference, and possibility to compare multiple scans. The main barriers to adoption related to the limited availability of 3T MRI scanners in the UK, integration into the clinical workflow, and the need to demonstrate cost-effectiveness. These findings will guide future technical development, clinical validation, and health economic evaluation.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Needs of key stakeholders to make advance care plans and advance directives for people with dementia - A scoping review 93%
- Ageing and Dementia: Age-Period-Cohort Effects of Policy Intervention in England, 2006-2016 92%
- Deconditioning in people living with dementia during the COVID-19 pandemic: findings from the Promoting Activity, Independence and Stability in Early Dementia (PrAISED) process evaluation 91%
Similar papers in this journal
- Examining heterogeneity in dementia using data-driven unsupervised clustering of cognitive profiles 93%
- Top-funded digital health companies offering lifestyle interventions for dementia prevention: Company overview and evidence analysis 93%
- Random forest model for feature-based Alzheimer's disease conversion prediction from early mild cognitive impairment subjects 92%
Similar papers in this journal
- Dementia diagnosis and prevalence in the Lothian Birth Cohort 1936 using medical data linkage 93%
- Implementing an Advance Choice Documents resource for Black African and Caribbean people with experience of compulsory psychiatric admission 85%
- A psychometric validation of the Hospital Anxiety and Depression Scale (HADS) in community-dwelling older adults 84%
Similar papers in this journal
- The New Therapeutics in Alzheimer’s Disease Longitudinal Cohort study (NTAD): study protocol 92%
- Developing a core outcome set for interventions in people with mild cognitive impairment: study protocol 92%
- Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies (WeSHARE) 92%
Similar papers in this journal
- A metabolite-based machine learning approach to diagnose Alzheimer's-type dementia in blood: Results from the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort 89%
- Association of the use of hearing aids with the conversion from mild cognitive impairment to dementia and progression of dementia: a longitudinal retrospective study 89%
- A ketogenic supplement improves white matter energy supply and processing speed in mild cognitive impairment 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.